Hypertension, Diabetes Type II, and Their Association: Role of Arterial Stiffness (Q38544227)

4 September 2017

1 reference

title

Hypertension, Diabetes Type II, and Their Association: Role of Arterial Stiffness (English)

1 reference

4 September 2017

0 references

Harold Smulyan

1

1 reference

PubMed ID

26156872

4 September 2017

Ari Lieber

series ordinal

2

1 reference

PubMed ID

26156872

4 September 2017

Michel E Safar

series ordinal

3

1 reference

4 September 2017

8 July 2015

1 reference

Journal of Clinical Hypertension

4 September 2017

1 reference

4 September 2017

29

1 reference

4 September 2017

5-13

1 reference

4 September 2017

1

1 reference

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study

4 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Blood pressure variables and cardiovascular risk: new findings from ADVANCE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

The Data from an Epidemiologic Study on the Insulin Resistance Syndrome Study: the change and the rate of change of the age-blood pressure relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Hypertension and vascular dynamics in men and women with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Aortic stiffness and cardiovascular risk in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Macrovascular and microvascular dysfunction in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part I: (Patho)-physiology, rationale and perspective on pulse pressure amplification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Chronic matrix metalloproteinase inhibition retards age-associated arterial proinflammation and increase in blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Rationale and study design of the Prospective comparison of Angiotensin Receptor neprilysin inhibitor with Angiotensin receptor blocker MEasuring arterial sTiffness in the eldERly (PARAMETER) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Arterial stiffening precedes systolic hypertension in diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Current strategies for evaluating, monitoring, and treating type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Defining and achieving treatment success in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Antidiabetic agents and cardiovascular risk in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Effects of intensive blood-pressure control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Arterial stiffness and cardiovascular events: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Mean and yearly changes in blood pressure with age in the metabolic syndrome: the DESIR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

Pulse wave analysis with two tonometric devices: a comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPV107

21 January 2018

Identifiers

DOI

10.1093/AJH/HPV107

1 reference

4 September 2017

1 reference

PubMed ID

26156872